NWMP
AZN icon

Noble Wealth Management PBC’s AstraZeneca AZN Stock Holding History

Noble Wealth Management PBC’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33K Buy
+7
New +$1.32K ﹤0.01% 658

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Noble Wealth Management PBC's AZN Position: Q2 2026 in Review

Noble Wealth Management PBC opened a new position in AstraZeneca (AZN) in Q2 2026: 7 shares worth $1.33K. The stake represents ﹤0.01% of the portfolio and ranks #658 among its holdings.

537 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Noble Wealth Management PBC held 7 shares of AstraZeneca worth $1.33K as of Q2 2026.
  • AstraZeneca was a new Noble Wealth Management PBC position in Q2 2026.
  • AstraZeneca made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q2 2026, its #658 holding.
  • 537 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Noble Wealth Management PBC's 13F filing for Q2 2026, filed 1 Jul 2026.